Lavielle R - Search Results

1

Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.

Bombois S, Maurage CA, Gompel M, Deramecourt V, Mackowiak-Cordoliani MA, Black RS, Lavielle R, Delacourte A, Pasquier F. Bombois S, et al. Among authors: lavielle r. Arch Neurol. 2007 Apr;64(4):583-7. doi: 10.1001/archneur.64.4.583. Arch Neurol. 2007. PMID: 17420322

2

Veno-occlusive disease after an anti-CD33 therapy (gemtuzumab ozogamicin).

Bastie JN, Suzan F, Garcia I, Isnard F, de Revel T, Terre C, Mayeur D, Abraham C, Lavielle R, Castaigne S. Bastie JN, et al. Among authors: lavielle r. Br J Haematol. 2002 Mar;116(4):924. doi: 10.1046/j.0007-1048.2002.03346.x. Br J Haematol. 2002. PMID: 11886404 Free article. No abstract available.

3

Therapeutic benefit of benfluorex in type II diabetic patients treated with sulfonylureas.

Stucci N, de Gregoris P, Lavielle R, Tomasi F. Stucci N, et al. Among authors: lavielle r. J Diabetes Complications. 1996 Sep-Oct;10(5):267-73. doi: 10.1016/1056-8727(96)00042-6. J Diabetes Complications. 1996. PMID: 8887015 Clinical Trial.

4

Chronobiometric identification of disorders of hunger sensation in essential obesity: therapeutic effects of dexfenfluramine.

Cugini P, Battisti P, Paggi A, Di Stasio ME, Di Palma L, Morelli F, Pisculli M, Lavielle R. Cugini P, et al. Among authors: lavielle r. Metabolism. 1995 Feb;44(2 Suppl 2):50-6. doi: 10.1016/0026-0495(95)90211-2. Metabolism. 1995. PMID: 7869939

5

Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus.

De Feo P, Lavielle R, De Gregoris P, Bolli GB. De Feo P, et al. Among authors: lavielle r. Diabetes Metab Rev. 1993 Nov;9 Suppl 1:35S-41S. doi: 10.1002/dmr.5610090507. Diabetes Metab Rev. 1993. PMID: 8299487 Clinical Trial. No abstract available.

6

Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabetic patients.

Andersen PH, Richelsen B, Bak J, Schmitz O, Sørensen NS, Lavielle R, Pedersen O. Andersen PH, et al. Among authors: lavielle r. Acta Endocrinol (Copenh). 1993 Mar;128(3):251-8. doi: 10.1530/acta.0.1280251. Acta Endocrinol (Copenh). 1993. PMID: 8480475 Clinical Trial.

7

Turnover and oxidation rates of plasma-free fatty acids in obese patients treated with dexfenfluramine.

Greco AV, Mingrone G, Tataranni PA, Raguso C, De Gaetano A, Tacchino RM, Lavielle R, Ghirlanda G. Greco AV, et al. Among authors: lavielle r. Ann Nutr Metab. 1993;37(5):237-44. doi: 10.1159/000177773. Ann Nutr Metab. 1993. PMID: 8311417

8

Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.

Glaser B, Raveh Y, Norynberg C, Berry E, Lavielle R, Nathan C, Cerasi E. Glaser B, et al. Among authors: lavielle r. Diabetes Res. 1992;19(4):165-76. Diabetes Res. 1992. PMID: 1343113 Clinical Trial.

9

History and evolution of the concept of oral therapy in diabetes.

Duhault J, Lavielle R. Duhault J, et al. Among authors: lavielle r. Diabetes Res Clin Pract. 1991;14 Suppl 2:S9-13. doi: 10.1016/0168-8227(91)90003-v. Diabetes Res Clin Pract. 1991. PMID: 1794272 Review.

10

The mode of action and clinical pharmacology of gliclazide: a review.

Campbell DB, Lavielle R, Nathan C. Campbell DB, et al. Among authors: lavielle r. Diabetes Res Clin Pract. 1991;14 Suppl 2:S21-36. doi: 10.1016/0168-8227(91)90005-x. Diabetes Res Clin Pract. 1991. PMID: 1794262 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters